Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

You do know it's an end of life story right? Kinda like compassionate use. It's not curing or eliminating anything but the patients worries. Whereas DMT for stroke is going after a treatment. Two completely different levels of hurdles to climb. However, surely the shrooms companies of the world, you know those with flying high all the time shareholders, will use it as some prop to pump their flailing stock.

Meanwhile, I'll take this opportunity to revise my own interpretive timeline for Algernon's pipeline. I continue to believe there will not be any clinical trials launched in 2022 other than DMT. The Cancer angles will be stalked just like DMT one quarter after the next (one more stalk and it will be a calendar year passing below your feet) until 2023. The Cancer angles will probably start sometime in 2023.

However, the start of the next Phase 2 study is thus far claimed to be DMT. I wouldn't expect Algernon to get to a data readout for DMT until Q4 2025 at best, but more likely in 2026. 2026 will be your 1st data readout powered for stat sig (maybe - gotta see it first) in the company's history. Moreau will have been at the helm going on 8 Years before he gets one real clinical trial completed at Phase 2 ("Everybody Wants In At Phase 2" - Moreau). It's the most pathetic timelines that are rife for minimum momentum and massive dilution.

Have @ it

M$